Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) FCF Margin: 2019-2023

Historic FCF Margin for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to -58,514.29%.

  • Benitec Biopharma's FCF Margin was N/A to -58,514.29% in Q2 2023 from the same period last year, while for Jun 2023 it was -14,644.72%, marking a year-over-year change of. This contributed to the annual value of -24,017.33% for FY2023, which is 221870.00% down from last year.
  • Per Benitec Biopharma's latest filing, its FCF Margin stood at -58,514.29% for Q2 2023, which was down 686.60% from -7,438.89% recorded in Q1 2023.
  • Benitec Biopharma's 5-year FCF Margin high stood at 9,022.86% for Q2 2020, and its period low was -347,400.00% during Q4 2020.
  • Its 3-year average for FCF Margin is -82,748.82%, with a median of -41,821.43% in 2022.
  • Per our database at Business Quant, Benitec Biopharma's FCF Margin plummeted by 34,340,519bps in 2020 and then spiked by 33,411,200bps in 2021.
  • Benitec Biopharma's FCF Margin (Quarterly) stood at -3,994.81% in 2019, then plummeted by 34,340,519bps to -347,400.00% in 2020, then skyrocketed by 33,411,200bps to -13,288.00% in 2021, then tumbled by 2,853,343bps to -41,821.43% in 2022, then slumped by 30,972bps to -58,514.29% in 2023.
  • Its FCF Margin was -58,514.29% in Q2 2023, compared to -7,438.89% in Q1 2023 and -41,821.43% in Q4 2022.